Bristol-Myers Squibb Co (NYSE:BMY)

During the Trading Day
49.11 +0.94 / +1.95%
Data as of 4:00pm ET
Day’s Change
During After-Hours   Switch to standard view »
49.11 0.00 / 0.00%
Volume: 51.2K
2 Reasons Why Merck & Co. Is Crushing the Dow
6:31pm /
3 Stocks Reiterated As A Buy: BMY, LOW, CSCO
Apr 11 /
Gilead Sciences, Inc. Feeling Sovaldi Pressure From All Sides
6:31pm /
Encouraging Data from Bristol-Myers - Analyst Blog
Apr 11 /
Could This Small-Cap Biotech's Experimental Diabetes Drug Be a Game Changer?
2:06pm /
Merck Shouts "Me, Too!" But Will It Matter?
Apr 11 /
3 Stocks Reiterated As A Buy: BMY, CELG, V
10:51am /
Market Hustle: Stock Futures Sink as JPMorgan's Profit Shrinks
Apr 11 /
Bristol-Myers Seeks Approval for HIV Combo Drug - Analyst Blog
Apr 15 /
Merck Up on Encouraging HCV Data - Analyst Blog
Apr 10 /
How Much Has Merck Shaken Up the Hepatitis C Race?
Apr 15 /
Stunning Spending Growth Prediction for Hepatitis C
Apr 10 /
Leaders Of The Pharmaceutical Pack
Apr 15 / StockTwits
Today's Biotech Stocks to Watch: Bristol-Myers Squibb, Gilead Sciences and Merck & Co...
Apr 10 /
Portola's Betrixaban Study Design Published - Analyst Blog
Apr 15 /
Pre-Open Stock Movers 3/17: (FPRX) (JASO) (SINA) Higher; (GTN) (VRSN) (GNC) Lower (mo...
Apr 09 / Investing Channel
This Forgotten Pharma Could Be a Hit for Your Portfolio
Apr 15 /
Oncolytics Reports Additional Data on Reolysin - Analyst Blog
Apr 09 /
Can Merck & Co. Inc. and Bristol-Myers Squibb Co. Dethrone Gilead Sciences Inc. for H...
Apr 15 /
Positive Trial Data Lifts Alkermes - Analyst Blog
Apr 09 /
Amgen's Conundrum
Apr 14 /
Bristol-Myers Seeks FDA Approval for HCV Candidates - Analyst Blog
Apr 08 /
Hard-to-Cure Patients May Benefit from Merck's HCV Drug - Analyst Blog
Apr 14 /
3 Under-Loved Dividend Darlings for Your Portfolio
Apr 04 /
Positive Data on AbbVie's HCV Program - Analyst Blog
Apr 14 /
Merck KGaA, Pfizer and Broad Institute Collaborate - Analyst Blog
Apr 03 /
Is This the Answer to Expensive Hepatitis-C Cures?
Apr 14 /
Forstmann Little eyes $2bn sale of 24 Hour Fitness chain
Apr 02 /
UPDATE: Bristol-Myers Squibb Submits NDA to US FDA for Fixed-Dose Combo Tablet for At...
Apr 14 / Benzinga
Bristol-Myers Squibb: side effects
Apr 01 /
Hedge Funds Love These 3 Pharma Stocks
Apr 14 / StreetAuthority

To view my watchlist

Not a member yet?

Sign up now for a free account
Market indexes are shown in real time, except for the DJIA, which is delayed by two minutes. All times are ET. Disclaimer LIBOR Warning: Neither BBA Enterprises Limited, nor the BBA LIBOR Contributor Banks, nor Reuters, can be held liable for any irregularity or inaccuracy of BBA LIBOR. Disclaimer. Morningstar: © 2014 Morningstar, Inc. All Rights Reserved. Disclaimer The Dow Jones IndexesSM are proprietary to and distributed by Dow Jones & Company, Inc. and have been licensed for use. All content of the Dow Jones IndexesSM © 2014 is proprietary to Dow Jones & Company, Inc. Chicago Mercantile Association. The market data is the property of Chicago Mercantile Exchange Inc. and its licensors. All rights reserved. FactSet Research Systems Inc. 2014. All rights reserved. Most stock quote data provided by BATS.